Publication | Closed Access
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib
34
Citations
37
References
2015
Year
Tumor BiologyMedicineReceptor Tyrosine KinaseMelanomaMelanoma CellsBraf Inhibitor VemurafenibAnti-cancer AgentPharmacologyCell BiologyCancer ResearchDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1